Table 3.
The raw normalized microarray data for selected lymphatic markers at different ages (E10–E20) and oxygen treatments are given.
| E10N | E10H | E14N | E14H | E17N | E17H | E20N | E20H | |
|---|---|---|---|---|---|---|---|---|
| Angiopoietin-2 | 1.007 | 0.906 | 1.166 | 1.071 | 0.944 | 1.04 | 0.918 | 0.712 |
| Elk3 (NET) | 1.242 | 1.335 | 1.598 | 1.355 | 0.874 | 0.881 | 0.84 | 0.803 |
| EphB4 | 1.162 | 1.349 | 0.764 | 0.992 | 1.014 | 0.87 | 1.087 | 1.058 |
| Ephrin B2 | 1.007 | 1.055 | 0.705 | 0.899 | 1.051 | 0.781 | 1.162 | 0.928 |
| Fiaf (Angpt4) | 1.111 | 1.053 | 1.274 | 1.114 | 0.935 | 0.827 | 0.988 | 0.878 |
| FoxC1 | 0.96 | 0.797 | 1.298 | 1.243 | 1.078 | 0.976 | 1.026 | 0.685 |
| FoxC2 | 0.913 | 0.894 | 0.887 | 0.972 | 0.934 | 1.007 | 0.985 | 1.026 |
| Integrin α9 | 0.785 | 0.901 | 0.602 | 1.056 | 1.236 | 0.704 | 1.305 | 1.065 |
| Integrin β1 | 0.653 | 0.762 | 1.043 | 0.995 | 0.857 | 1.116 | 0.965 | 1.03 |
| Lyve1 | 0.932 | 0.841 | 1.105 | 1.122 | 1.095 | 0.981 | 1.171 | 0.873 |
| Nrp2 | 1.106 | 0.8 | 1.662 | 1.249 | 1.092 | 0.955 | 0.973 | 0.568 |
| Podoplanin | 0.683 | 0.849 | 0.761 | 0.852 | 1.236 | 0.871 | 2.159 | 1.507 |
| Prox1 | 0.982 | 1.031 | 1.031 | 1.163 | 0.994 | 0.695 | 0.952 | 0.785 |
| SLC (CCL21) | 0.997 | 1.127 | 0.739 | 0.839 | 0.994 | 1.08 | 1.003 | 1.075 |
| Slp76 (Lcp2) | 1.298 | 1.021 | 0.631 | 0.903 | 0.994 | 0.797 | 1.163 | 1.069 |
| SOX18 | 1.027 | 0.949 | 1.107 | 1.021 | 0.933 | 0.908 | 0.943 | 0.97 |
| Syk | 1.07 | 1.205 | 1.57 | 1.184 | 1.199 | 0.993 | 0.858 | 1.026 |
| Tie2 | 0.872 | 0.942 | 0.793 | 1.226 | 1.358 | 1.093 | 1.564 | 0.779 |
| Trpv1 | 1.953 | 1.531 | 1.95 | 1.563 | 0.884 | 0.789 | 1.062 | 0.748 |
| VEGF-C | 1.215 | 1.024 | 1.365 | 1.329 | 1.058 | 1.024 | 0.952 | 0.807 |
| VEGF-D | 1.476 | 1.277 | 1.105 | 1.034 | 0.866 | 1.091 | 1.009 | 0.758 |
| VEGFR-3 | 0.919 | 0.992 | 0.898 | 0.818 | 1.083 | 0.932 | 1.226 | 1.362 |